Utama › Kegagalan Jantung › California › San Francisco
Kajian klinikal Kegagalan Jantung di San Francisco, CA
29 kajian untuk Kegagalan Jantung sedang mencari peserta di lokasi dalam dan sekitar San Francisco (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
ELEVATE-HFpEF Clinical Study
Mengambil peserta
- Sutter Health Hospital, San Francisco
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Mengambil pesertaFasa 3
- Research Site, San Francisco
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
Mengambil pesertaFasa 2
- University of California, San Francisco, San Francisco
- University of California San Francisco UCSF, San Francisco
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Mengambil pesertaFasa 3
- California Pacific Medical Center Van Ness Campus, San Francisco
Alleviant ALLAY-HFrEF Study
Mengambil peserta
- University of California San Francisco, San Francisco
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Mengambil pesertaFasa 3
- Kaiser Permanente, San Francisco
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Mengambil pesertaFasa 3
- Research Site, San Francisco
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Mengambil pesertaFasa 3
- San Francisco, CA Investigative Site CON-10315, San Francisco
- CON-10023, San Francisco, CA, San Francisco
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Mengambil pesertaFasa 3
- San Francisco, CA Investigative Site 10023, San Francisco
Remote Dielectric Sensing (ReDS) Assisted Diuresis in Acute Decompensated Heart Failure
Mengambil peserta
- University of California, San Francisco, San Francisco
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
Mengambil pesertaFasa 2
- University of California, San Francisco - Heart and Vascular Center, San Francisco
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Mengambil peserta
- Zuckerberg San Francisco General, San Francisco
- University of California San Francisco, San Francisco
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Mengambil pesertaKajian pemerhatian
- University Of California San Francisco Medical Center, San Francisco
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Mengambil pesertaFasa 3
- Tenax Investigational Site, San Francisco
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Mengambil pesertaFasa 3
- Kaiser Permanente Northern California, San Francisco
- San Francisco V.A. Medical Center, San Francisco
Alleviant ALLAY-HF Study
Mengambil peserta
- University of California San Francisco, San Francisco
Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
Mengambil pesertaFasa 3
- UC San Francisco Medical Center, San Francisco
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
Mengambil pesertaFasa 3
- San Francisco, CA Investigative Site FIN-10023, San Francisco
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Mengambil peserta
- UCSF Medical Center, San Francisco
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Mengambil peserta
- University of California at San Francisco, San Francisco
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
Mengambil pesertaFasa 3
- UC San Francisco Medical Center, San Francisco
- UC San Francisco Medical Center, San Francisco
Developing a Digital Aid to Improve ICD Decisions
Mengambil peserta
- University of California, San Francisco, San Francisco
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Mengambil peserta
- University of California- San Francisco, San Francisco
Voice Analysis to Detect Pulmonary Arterial Pressure Changes in Heart Failure
Mengambil pesertaKajian pemerhatian
- University of California, San Francisco (UCSF), San Francisco
Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future
Mengambil pesertaKajian pemerhatian
- UCSF, San Francisco
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
Mengambil pesertaKajian pemerhatian
- University of California, San Francisco, San Francisco
- Kaiser Permanente San Francisco, San Francisco
Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC
Mengambil pesertaFasa 1
- University of California San Francisco, San Francisco
Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
Mengambil pesertaKajian pemerhatian
- University of California San Francisco, San Francisco
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Mengambil pesertaFasa 1/2
- University of California, San Francisco, San Francisco
Kajian Kegagalan Jantung di bandar lain
- New York City, NY51 kajian
- Boston, MA44 kajian
- Dallas, TX42 kajian
- Houston, TX36 kajian
- Cleveland, OH33 kajian
- Chicago, IL31 kajian
- Philadelphia, PA31 kajian
- St. Louis, MO26 kajian
- Durham, NC26 kajian
- Atlanta, GA25 kajian
- Kansas City, MO25 kajian
- Baltimore, MD24 kajian
Kajian lain di San Francisco
- Kanser Prostat45 kajian
- Kanser Payudara43 kajian
- Kanser Paru-paru Bukan Sel Kecil36 kajian
- Kanser (semua jenis)35 kajian
- Kanser Metastatik28 kajian
- Kanser Paru-paru23 kajian
- Melanoma22 kajian
- Kanser Pankreas20 kajian
- Kanser Ovari19 kajian
- Kanser Kolorektal18 kajian
- Penyakit Kardiovaskular18 kajian
- Glioblastoma17 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.